Mirror Now
@mirrornow·2.2M subscribers·145K videos
Biophore to manufacture COVID drug Favipiravir; gets clearance to export the drug
Posted
July 14, 2020
Views
271
Likes
4
Engagement
1.48%
July 14, 2020
271
4
1.48%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
1:09Now PlayingAfter a huge spike in COVID cases in India, Biophore India pharmaceuticals have now received the license from the Drug Controller General of India to manufacture the drug Favipiravir which is an active ingredient that is used to treat mild to moderate COVID-19 infection in cases and symptoms. The DCGI's nod to produce the drug in India is also being cleared for exports as well. It has also received the approval in Turkey to export the API in collaboration with local partners additionally. The company is also in talks with several Indian partners to commercialize the product in India. Watch the video to know more!
SUBSCRIBE NOW for more such videos ►
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
